Bionano Genomics, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Bionano Genomics, Inc. on February 23, 2022, reporting events occurring on February 17, 2022. The filing pertains to corporate governance changes, specifically the appointment of a new director to the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel appointments and does not contain financial performance data.
Material Changes
The primary material change reported is the appointment of Aleksandar Rajkovic, M.D., Ph.D., as a Class III director, effective February 17, 2022. His term will serve until the Company's 2024 annual meeting of stockholders.
Compensation and Governance Details
- Cash Compensation: Dr. Rajkovic will receive an annual cash compensation of $40,000, payable in equal quarterly installments and pro-rated based on days served.
- Equity Grant: On February 17, 2022, Dr. Rajkovic was granted a stock option to purchase 194,986 shares of common stock under the 2018 Equity Incentive Plan.
- Vesting Schedule: The option vests in equal monthly installments over a three-year period, contingent on continuous service. Full vesting occurs upon a Change in Control.
- Indemnification: The Company has executed a standard indemnification agreement with Dr. Rajkovic.
Outlook and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary on business strategy, or specific risk factors beyond standard governance disclosures.
Key Facts for Investor Verification
- Confirm the effective date of Dr. Rajkovic's directorship (February 17, 2022).
- Verify the total number of shares subject to the initial stock option grant (194,986 shares).
- Review the vesting terms to understand the timeline for equity realization (36 months).
- Check the Company's 2018 Equity Incentive Plan for details on the "Change in Control" acceleration clause.